TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
Sports
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | United StatesPakistan
Diaspora
Features | Time CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
UPSC | Exam ScheduleExam Mentor
Advertisement

Airbus first-quarter core profit plunges 49%

Planemaker says will focus squarely on saving cash
Advertisement

Paris, April 29

Advertisement

Planemaker Airbus (AIR.PA) on Wednesday posted a 49% slump in first-quarter adjusted operating profit to 281 million ($304.7 million) as revenue dropped 15% to 10.631 billion amid the “gravest crisis the aerospace industry has ever known”.

Advertisement

Europe’s largest aerospace group also reported a negative cashflow of 8.03 billion, including a previously published record fine of 3.6 billion to settle bribery and corruption investigations in Britain, France and the United States.

Planemakers, airlines and suppliers have been left reeling by the coronavirus pandemic, which has crippled passenger travel and catapulted major economies into recession.

Airbus suspended its profit outlook, scrapped its dividend and negotiated new commercial credit lines last month as the spread of the coronavirus began to impact airline operations and almost halted the delivery of aircraft.

Advertisement

Several other top aerospace firms are also expected to report weaker results on Wednesday, including US rival Boeing (BA.N), which is also hit by the continued grounding of its 737 MAX, though the impact of the coronavirus is mostly expected in the second quarter.

Airbus said it would focus squarely on saving cash. The France-based group will reduce 2020 capital expenditure by around 700 million to around 1.9 billion and defer or suspend activities which are “not critical to business continuity” or meeting other commitments. — Reuters

Advertisement
Show comments
Advertisement